Health Trials

Donafenib

1

Review clinical trials related to Donafenib. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

This study intends to evaluate the efficacy and safety of low-dose adjuvant donafenib after thermal ablation for early recurrent HCC within Milan criteria.

Participants needed: 108
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Dec 3, 2024Locations: 1
Eligibility criteria

were aged 18-75 years; [+7]

were under 18 years or over 75 years of age; [+3]

Read more